# OnCo record nct05804370 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05804370/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05804370", "NCT05804370" ;
  schema:name "Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)"@en ;
  schema:description "A phase 3 trial of 5-Aminolevulinic acid in ovarian cancer, run by NX Development Corp, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05804370/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05804370> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-05-30" ;
  onco:cancers <https://onco.cc/cancers/ovarian/> ;
  onco:technologies <https://onco.cc/technologies/fluorescence-guided-surgery/>, <https://onco.cc/technologies/optical-imaging/> ;
  onco:drugs <https://onco.cc/drugs/aminolevulinic-acid-gleolan/> .